Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

v3.22.4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
 9 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Cash flows from operating activities:    
Net loss $ (4,189,655) $ (2,816,454)
Adjustments to reconcile net loss to net cash used in operating activities:    
Other non-cash expense 165,868 0
Stock issued for services 2,278 31,773
Stock issued for compensation 7,334 30,396
Stock-based compensation 638,072 41,893
Change in assets and liabilities:    
Increase in prepaid expenses and other current assets (86,836) (100,970)
Increase in other assets 0 (316)
Increase (decrease) in accounts payable 74,706 (79,399)
Decrease in accrued expenses (117,110) (32,402)
Net cash used in operating activities (3,505,343) (2,925,479)
Cash flows from investing activities:    
Net cash provided by (used in) investing activities 0 0
Cash flows from financing activities:    
Repurchase of common stock (9,254,005) 0
Proceeds from issuance of pre-funded warrants 0 31,669,027
Proceeds from sale of common stock, net of issuance costs 0 55,693,022
Proceeds from warrant exercise 880 0
Net cash provided (used) in financing activities (9,253,125) 87,362,049
Effect of currency rate exchange on cash and cash equivalents (1,970) 1,081
Net increase (decrease) in cash and cash equivalents (12,760,438) 84,437,651
Cash and cash equivalents at beginning of the period 85,400,656 2,202,106
Cash and cash equivalents at end of the period 72,640,218 86,639,757
Supplemental disclosure of cash flows information:    
Cash paid during the periods for income taxes 0 1,600
Cash paid during the periods for interest 0 509
Non-cash equity issuance costs $ 0 $ 34,477,000